EPISODE · Jul 10, 2019 · 11 MIN
The Stock Day Podcast Hosts CytoDyn to Discuss The Addition of Dr. Jonah Sacha to their Team
from Stock Day Media · host Stock Day Media
The Stock Day Podcast welcomed CytoDyn (CYDY)(“the Company”), a biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. CEO and President, Nader Pourhassan, Ph.D., joined Stock Day host Everett Jolly. Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
Embed this episode
Ready to play
The Stock Day Podcast Hosts CytoDyn to Discuss The Addition of Dr. Jonah Sacha to their Team
No transcript for this episode yet
Similar Episodes
No similar episodes found.